Medpace Stock News
$501.22
3.37%
Nasdaq,
Oct 10, 10:00 pm CET
Index
Industry
Medpace Stock News
Neutral
Business Wire
●
20 days ago
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2025 financial results after the market close on Wednesday, October 22, 2025. The Company will host a conference call the following morning, Thursday, October 23, 2025, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested par...
Positive
Seeking Alpha
●
26 days ago
For this year, Medpace expects that its revenues will increase by 17.1%, which is an excellent growth rate. From 2019 to Q2 2025, Medpace's outstanding common shares declined by 22.16%, creating value for its investors. In the first half of 2025, the company had a capex-to-revenues ratio of 1.39%, which contributed to the company's high net profit margin.
Positive
Investors Business Daily
●
about 2 months ago
Health care stock Medpace Holdings soared to an all-time high after second-quarter results. Shares are in a 5% buy zone,.
Positive
Seeking Alpha
●
2 months ago
Medpace delivered a stunning Q2 2025, with double-digit revenue and net new awards growth, defying widespread healthcare sector pessimism. The company achieved 14% YoY revenue growth and 18.6% EBITDA growth, far surpassing expectations, and increased guidance for the year. Management accelerated opportunistic share buybacks, returning $908 million to shareholders in the first half of 2025, demo...
Positive
The Motley Fool
●
3 months ago
Medpace (MEDP 54.51%), a clinical contract research organization that manages drug development for pharmaceutical and biotech clients, reported its second quarter 2025 earnings on July 17, 2025. The company delivered GAAP results that topped both earnings and revenue forecasts, with GAAP revenue of $603.3 million versus the estimated $538.8 million and GAAP earnings per share (EPS) of $3.10 ver...
Neutral
Seeking Alpha
●
3 months ago
Medpace Holdings, Inc. (NASDAQ:MEDP ) Q2 2025 Earnings Conference Call July 22, 2025 9:00 AM ET Company Participants August James Troendle - Chairman & CEO Jesse J. Geiger - President Kevin M.
Neutral
Seeking Alpha
●
3 months ago
Medpace's Global CRO Reach Lends Credibility For Its 2025 Revenue Guidance Increase
Positive
Barrons
●
3 months ago
If gains hold, that'd be the stock's largest single-day increase on record.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
